August 22, 2023
The Big Question on the Minds of Every 340B Stakeholder
The Big Question on the Minds of Every 340B Stakeholder By Ted Slafsky As we pass the third anniversary of the pharmaceutical industry’s surprise decision to significantly scale back access to 340B pricing in the contract pharmacy setting, the key question is: Why is it taking so long to come up with a resolution? One […]